Italian multicenter survey to evaluate the opinion of patients and their reference clinicians on the "tolerance" to targeted therapies already available for non-small cell lung cancer treatment in daily clinical practice.


INTRODUCTION The introduction of targeted therapies in non-small cell lung cancer (NSCLC) treatment has led to emerging toxicities, whose management and impact on quality-of-life (QoL) is not clearly defined. Aim of this Italian multicenter survey was to highlight any discrepancy between patients' and clinicians' perception of such toxicities in order to… (More)
DOI: 10.3978/j.issn.2218-6751.2014.06.10


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics